Minerva Neurosciences (NERV) Misses Q4 EPS by 153c

Minerva Neurosciences (NASDAQ: NERV) reported Q4 EPS of ($0.56), $1.53 worse than the analyst estimate of $0.97.

For earnings history and earnings-related data on Minerva Neurosciences (NERV) click here.

You May Also Be Interested In

• Rockstar Energy founder seeks CEO role at Celsius Holdings
• SpyGlass Pharma (SGP) Reports Q2 Loss of $0.59
• Atlassian results seen as 'game changer' for AI kills software worries